CD40LG and diabetes mellitus: Interfering with the CD40-CD154 interaction by monoclonal antibodies, soluble ligands or antisense oligonucleotides has been successfully applied to mouse models of autoimmune disease, such as diabetes, transplant rejection, and EAE, but has not been studied before in animal models of SS.